Skip to main content

Table 1 Tumor characteristics named as relevant for treatment decision

From: Radiotherapy for pelvic nodal recurrences after radical prostatectomy: patient selection in clinical practice

Characteristic

% (number of centers)

PSA doubling time

57% (n = 8)

Initial high-risk disease

36% (n = 5)

PSA level at recurrence

29% (n = 4)

Size of lymph node recurrence

14% (n = 2)

Interval since RP

14% (n = 2)

  1. Multiple factors were named by some centers. PSA, prostate-specific antigen. RP, radical prostatectomy.
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us